経口補水塩市場：タイプ、用途、流通チャネル、地域別、2024年～2031年

経口補水塩市場の評価、2024年～2031年

下痢、熱中症、胃腸感染症など、脱水症に関連する症状の有病率の上昇により、効果的な経口補水液の需要が高まっています。ORSは、これらの症状の結果として失われる水分と電解質を補給する能力で広く認知されており、2024年には7億4,297万米ドルを超え、2031年には17億4,710万米ドルに達します。

さらに、保健機関や政府によるORSの利点に関する認識や教育キャンペーンの増加が、特に脱水症状の発生率が高い地域での使用促進に役立っています。薬局やeコマース・プラットフォームなどの流通チャネルの拡大は、入手しやすさと可用性を高め、市場成長を加速させ、2024年～2031年の間に11.28％のCAGRで成長する見込みです。

経口補水塩市場定義/概要

経口補水塩（ORS）は、特に下痢、嘔吐、熱ストレスによって引き起こされる脱水を予防・治療する治療薬です。ORSは塩と糖の正確な混合物から成り、水に溶かすと体内の失われた水分と電解質の補給を助ける。その有効性と使いやすさから、ORSは臨床現場だけでなく家庭でも広く使われています。ORSの将来には、予防衛生対策や緊急事態、特に脱水症状の発生率が高い新興諸国での使用拡大が含まれます。ORSの世界の成長と普及の原動力となるのは、製剤と供給方法の進歩、そして人々の認識と入手しやすさの向上であろう。

保健機関別教育キャンペーンによる認知度の向上は経口補水塩市場を促進するか？

保健機関による教育キャンペーンに後押しされた認知度の上昇が、経口補水塩（ORS）市場を大きく押し上げると予想されます。健康キャンペーンは、特に下痢や関連疾患の発生率が高い地域において、脱水症状の管理におけるORSの重要性に対する国民の意識を高める上で極めて重要です。例えば、2023年9月、世界保健機関（WHO）は、ORSの利点を促進するための世界的イニシアチブを立ち上げ、脱水症関連の死亡率を低下させる効果を強調しました。こうした取り組みは、ORSの認知度を高めるだけでなく、臨床現場や家庭での使用も奨励しています。教育的な取り組みは、ORSの適切な使用と入手のしやすさを強調し、需要の増加と市場の成長に貢献します。

さらに、地元の保健省や非政府組織（NGO）は、十分なサービスを受けていない地域でのORS使用を積極的に推進しています。例えば、2023年8月、インドの全国農村保健ミッション（National Rural Health Mission）は、農村部の人々にORSの入手可能性と利点を啓蒙する大規模なキャンペーンを開始しました。このキャンペーンは、こうした地域でのORS消費量の増加に成功し、一般市民の認知度向上が市場拡大に直接的な影響を与えるという大きな動向を示しています。保健機関による教育支援活動が重視されるようになったことで、一般市民はより良い情報を得ることができ、ORSの普及が促進され、市場が前進しています。

サプライチェーン問題の増加は経口補水塩市場の成長を妨げるか？

サプライチェーン問題の高まりは、製造・流通プロセスを混乱させることで、経口補水塩（ORS）市場の成長を大きく阻害する可能性があります。こうした混乱は製造や出荷の遅れを引き起こし、重要な地域でのORS製品の入手を制限する可能性があります。供給が安定しないことで、特に脱水症状の発生率が高い地域では、緊急ニーズへの対応能力が損なわれる可能性があります。さらに、サプライチェーンの問題は運営コストを上昇させ、その結果ORS製品の価格が上昇し、低所得層がORSを利用しにくくなる可能性があります。

さらに、サプライチェーンの混乱はORS製品の品質と安全性を損なう可能性があります。原材料調達の遅れや問題は、品質管理の問題や規格外の原材料の使用につながる可能性があります。その結果、消費者の信頼が損なわれ、規制当局の監視を受けることになり、市場拡大努力が複雑になる可能性があります。こうしたリスクを軽減するため、ORS市場の利害関係者は、より強靭なサプライチェーン戦略に投資し、物流調整を改善し、厳格な品質管理手順を実施しなければならないです。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 経口補水塩市場：タイプ別

• グルコースベースのORS
• 米ベースのORS
• 柑橘類ベースのORS
• 特定の病状に合わせたカスタム処方

第5章 経口補水塩市場：用途別

• 下痢による脱水症状の治療
• 嘔吐による脱水症状の治療
• スポーツ時の水分補給
• 激しい運動後の水分補給

第6章 経口補水塩市場：流通チャネル別

• 薬局
• 病院および診療所
• オンライン小売プラットフォーム
• スーパーマーケット、コンビニエンスストア

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Otsuka Pharmaceutical Co. Ltd.
• Monico Spa
• Gebro Pharma AG
• Primmed B.V.
• KBI Pharmaceuticals GmbH & Co. KG
• Nutriset
• Clinova Ltd.
• FDC Limited
• Watson Pharma（part of AbbVie）
• Sanofi S.A.

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Oral Rehydration Salts Market Valuation - 2024-2031

The rising prevalence of dehydration-related conditions, such as diarrhea, heat exhaustion, and gastrointestinal infections, is increasing demand for effective rehydration solutions. ORS is widely recognized for its ability to replenish fluids and electrolytes lost as a result of these conditions surpassing USD 742.97 Million in 2024 and reachingUSD 1747.1 Million by 2031.

Furthermore, increased awareness and educational campaigns about the benefits of ORS by health organizations and governments help to promote its use, especially in areas with high rates of dehydration. The expansion of distribution channels, such as pharmacies and e-commerce platforms, increases accessibility and availability, accelerating market growth is expected to grow at aCAGR of about 11.28% from 2024 to 2031.

Oral Rehydration Salts Market: Definition/ Overview

Oral Rehydration Salts (ORS) are a medical treatment that prevents and treats dehydration, particularly when caused by diarrhea, vomiting, or heat stress. They are made up of a precise mixture of salts and sugars that, when dissolved in water, help replenish the body's lost fluids and electrolytes. Because of its effectiveness and ease of use, ORS is widely used in clinical settings as well as at home. The future of ORS includes increased use in preventive health measures and emergency situations, particularly in developing countries with high rates of dehydration. Advances in formulation and delivery methods, as well as increased public awareness and accessibility, are expected to drive ORS's global growth and adoption.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Awareness of Educational Campaigns by Health Organization Propel the Oral Rehydration Salts Market?

Rising awareness, fueled by educational campaigns from health organizations, is expected to significantly boost the Oral Rehydration Salts (ORS) market. Health campaigns are critical in raising public awareness of the importance of ORS in managing dehydration, especially in areas with high rates of diarrhea and related conditions. For instance, in September 2023, the World Health Organization (WHO) launched a global initiative to promote the benefits of ORS, emphasizing its effectiveness in lowering dehydration-related mortality rates. Such initiatives not only raise awareness of ORS, but also encourage its use in clinical and home settings. The educational efforts emphasize proper use and accessibility of ORS, which contributes to increased demand and market growth.

Furthermore, local health departments and non-governmental organizations (NGOs) have actively promoted ORS use in underserved areas. For instance, in August 2023, India's National Rural Health Mission launched a major campaign to educate rural populations about the availability and benefits of ORS. This campaign has successfully increased ORS consumption in these communities, demonstrating a larger trend in which increased public awareness has a direct impact on market expansion. The growing emphasis on educational outreach by health organizations ensures a better-informed public and drives ORS adoption, propelling the market forward.

Will Rising Supply Chain Issues Hinder the Growth of the Oral Rehydration Salts Market?

Rising supply chain issues may significantly impede the growth of the oral rehydration salts (ORS) market by disrupting the manufacturing and distribution processes. These disruptions can cause delays in manufacturing and shipping, limiting the availability of ORS products in critical regions. Inconsistent supply can impair the market's ability to respond to urgent needs, especially in areas with a high incidence of dehydration-related conditions. Furthermore, supply chain issues may raise operational costs, resulting in higher ORS product prices and potentially limiting accessibility for low-income populations.

Furthermore, supply chain disruptions can compromise the quality and safety of ORS products. Delays or problems with raw material procurement can result in quality control issues or the use of substandard ingredients. This can erode consumer trust and result in regulatory scrutiny, complicating market expansion efforts. To mitigate these risks, stakeholders in the ORS market must invest in more resilient supply chain strategies, improve logistical coordination, and implement strict quality control procedures.

Category-Wise Acumens

Will Rising Demand of Glucose-Based ORS Propel the Growth of Oral Rehydration Salts Market?

The rising demand for glucose-based Oral Rehydration Salts (ORS) is expected to significantly boost the oral rehydration salts market. Glucose-based ORS is becoming increasingly popular due to its superior effectiveness in rehydrating and restoring electrolytes compared to traditional formulations. This preference stems from a growing understanding of the benefits of glucose in aiding the absorption of sodium and water in the intestine.

In July 2024, HealthPlus Pharmaceuticals introduced a new line of glucose-based ORS aimed at improving rehydration efficiency and patient compliance. This product introduction is consistent with the broader trend toward advanced ORS formulations. Furthermore, in August 2024, the World Health Organization (WHO) updated its ORS guidelines, recommending glucose-based formulations for improved dehydration treatment efficacy. This endorsement from a leading global health authority is expected to increase market adoption and growth. Such developments reflect a significant shift in the ORS market toward glucose-based solutions, which are characterized by superior performance and strong institutional support.

However, custom formulations for specific medical conditions are the fastest growing segment. This growth is being driven by an increase in demand for personalized healthcare solutions that are tailored to individual medical needs and conditions. Custom ORS formulations are gaining popularity because they provide targeted treatment options for health issues other than general dehydration, such as specific electrolyte imbalances and chronic illnesses. This trend reflects a shift toward more specialized and effective therapeutic solutions, which address a wider range of medical conditions and improve patient outcomes.

Will Rising Sales within Pharmacies Dominate the Oral Rehydration Salts Market?

Pharmacy sales are expected to continue to dominate the oral rehydration salts (ORS) market due to their established role as primary points of sale for health-related products. Pharmacies provide easy access to ORS, which is critical for consumers who require immediate treatment for dehydration, particularly in emergency situations. The widespread availability of ORS in pharmacies ensures that it remains the primary source of relief for people suffering from dehydration caused by conditions such as diarrhea or vomiting. This dominance is reinforced by pharmacies' ability to provide expert advice and guidance on the proper use of ORS products, which increases consumer trust and preference.

Furthermore, major pharmacy chains like Walgreens and CVS have expanded their ORS product lines in response to rising consumer demand. In June 2024, Walgreens announced a new partnership with a leading ORS manufacturer to increase inventory and ensure consistent supply across its stores, reflecting the growing importance of pharmacies as critical distribution points. This focus on pharmacies emphasizes their critical role in driving the ORS market, which has been supported by recent industry strategic moves.

Online retail platforms are the fastest growing market segment. This rapid growth is being driven by an increasing shift toward e-commerce, which is driven by consumer preferences for convenience and the ability to easily compare products and prices. Online platforms provide a diverse range of ORS products, including custom formulations and specialized options, appealing to a growing number of consumers seeking personalized solutions and home delivery services. This trend demonstrates the growing importance of digital shopping in meeting consumer needs and preferences.

Country/Region-wise

Will High Prevalence of Dehydration-Related Conditions in Asia Pacific Drive the Oral Rehydration Salts Market?

The high prevalence of dehydration-related conditions in Asia Pacific is fueling the oral rehydration salts (ORS) market. The region experiences frequent bouts of diarrhea and dehydration, especially in low-income and rural areas, necessitating a steady supply of ORS to effectively manage these conditions. Government initiatives and international health organizations are actively promoting ORS as a cost-effective treatment for dehydration, which is contributing to increased demand. For instance, in August 2023, the World Health Organization (WHO) expanded its ORS distribution programs in India and Bangladesh, with the goal of lowering dehydration-related mortality rates. This ongoing support emphasizes ORS's critical role in managing public health crises in the region.

Additionally, in September 2023, India's Ministry of Health and Family Welfare launched a new campaign to increase ORS availability and accessibility in rural health centers. This initiative is part of a larger strategy to improve maternal and child health, highlighting the growing importance of ORS as a key component of national health programs. The combination of high disease prevalence and strong government and international support is driving the growth of the ORS market in Asia Pacific, making it a critical region for market expansion and development.

Will Increasing Awareness of ORS Application in North America Propel the Oral Rehydration Salts Market?

The growing awareness of oral rehydration salts (ORS) applications in North America is expected to drive the ORS market significantly. In recent years, ORS has gained recognition as an effective solution for managing dehydration caused by gastrointestinal conditions, as well as for sports and exercise-related hydration. For instance, in June 2023, the United States Food and Drug Administration (FDA) approved new guidelines for the use of ORS in sports medicine, recognizing its benefits for athletes and active people. This endorsement has increased consumer awareness, resulting in a surge in demand for ORS products in pharmacies and sports nutrition stores.

Furthermore, educational campaigns and collaborations between health organizations and ORS manufacturers have played an important role in raising awareness. In August 2024, the Centers for Disease Control and Prevention (CDC) launched a major health initiative aimed at promoting ORS use for preventing dehydration in both children and adults, thereby boosting market growth. These efforts are bolstered by an increasing number of retail and online platforms that sell ORS products, making them more accessible to the North American public and propelling the market forward.

Competitive Landscape

The competitive landscape of the oral rehydration salts (ORS) market is characterized by a diverse array of companies offering various formulations to meet the growing demand. Companies are focusing on innovation, such as improving the taste and efficacy of ORS products, and expanding their distribution networks to enhance market reach. Additionally, partnerships with healthcare organizations and government initiatives to promote ORS use in combating dehydration are influencing the competitive dynamics. The market is also seeing increased investment in research and development to cater to specific regional needs and address emerging health challenges.

Some of the prominent players operating in the oral rehydration salts market include:

Otsuka Pharmaceutical Co. Ltd.

Monico Spa

Gebro Pharma AG

Primmed B.V.

KBI Pharmaceuticals GmbH & Co. KG

Nutriset

Clinova Ltd.

FDC Limited

Watson Pharma

Sanofi S.A.

Latest Developments

In February 2024, Procter & Gamble has announced the release of a new ORS formula aimed at improving taste and effectiveness. The new formula aims to improve patient compliance, especially in pediatric applications. This development is likely to increase P&G's market share in the ORS segment.

In July 2024, UNICEF has launched a new ORS distribution program geared toward emergency relief operations in conflict zones. The program seeks to address acute dehydration crises in affected areas through increased donations and international cooperation.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Oral Rehydration Salts Market, By Type

• Glucose-based ORS
• Rice-based ORS
• Citrus-based ORS
• Custom formulations for specific medical conditions

5. Oral Rehydration Salts Market, By Application

• Treatment of dehydration due to diarrhea
• Treatment of dehydration due to vomiting
• Sports hydration
• Rehydration after strenuous physical activity

6. Oral Rehydration Salts Market, By Distribution Channel

• Pharmacies
• Hospitals and clinics
• Online retail platforms
• Supermarkets and convenience stores

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Otsuka Pharmaceutical Co. Ltd.
• Monico Spa
• Gebro Pharma AG
• Primmed B.V.
• KBI Pharmaceuticals GmbH & Co. KG
• Nutriset
• Clinova Ltd.
• FDC Limited
• Watson Pharma (part of AbbVie)
• Sanofi S.A.

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References